Bentham Science Logo

Track Your Manuscript:


Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 20, 4 Issues, 2020
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Cardiovascular & Hematological Disorders-Drug Targets , Volume 9 - Number 3



Role of PI3K/AKT, cPLA2 and ERK1/2 Signaling Pathways in Insulin Regulation of Vascular Smooth Muscle Cells Proliferation

, 9(3): 172 - 180

Esma R. Isenovic, Mamdouh H. Kedees, Snezana Tepavcevic, Tijana Milosavljevic, Goran Koricanac, Andreja Trpkovic and Pierre Marche


DOI: 10.2174/187152909789007034



Investigational Positive Inotropic Agents for Acute Heart Failure

, 9(3): 193 - 205

Juan Tamargo, Ricardo Caballero, Ricardo Gomez, Adriana Barana, Irene Amoros and Eva Delpon


DOI: 10.2174/187152909789007070





Editor-in-Chief

Garry X. Shen
University of Manitoba
Winnipeg, MB
(Canada)

Biography View Full Editorial Board

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.46

New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Advertisement

MANAGING MEDICAL WRITINGCord Blood Awareness MonthCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog